755 related articles for article (PubMed ID: 31073888)
1. Exosomes: cell-created drug delivery systems.
Familtseva A; Jeremic N; Tyagi SC
Mol Cell Biochem; 2019 Sep; 459(1-2):1-6. PubMed ID: 31073888
[TBL] [Abstract][Full Text] [Related]
2. Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools.
Li SP; Lin ZX; Jiang XY; Yu XY
Acta Pharmacol Sin; 2018 Apr; 39(4):542-551. PubMed ID: 29417947
[TBL] [Abstract][Full Text] [Related]
3. Using exosomes, naturally-equipped nanocarriers, for drug delivery.
Batrakova EV; Kim MS
J Control Release; 2015 Dec; 219():396-405. PubMed ID: 26241750
[TBL] [Abstract][Full Text] [Related]
4. Exosome-like Nanovectors for Drug Delivery in Cancer.
Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E
Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846
[TBL] [Abstract][Full Text] [Related]
5. Engineering exosomes as refined biological nanoplatforms for drug delivery.
Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
[TBL] [Abstract][Full Text] [Related]
6. Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity.
Ferguson SW; Nguyen J
J Control Release; 2016 Apr; 228():179-190. PubMed ID: 26941033
[TBL] [Abstract][Full Text] [Related]
7. Exosome: a significant nano-scale drug delivery carrier.
Peng H; Ji W; Zhao R; Yang J; Lu Z; Li Y; Zhang X
J Mater Chem B; 2020 Sep; 8(34):7591-7608. PubMed ID: 32697267
[TBL] [Abstract][Full Text] [Related]
8. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
9. Drug loading techniques for exosome-based drug delivery systems.
Xi XM; Xia SJ; Lu R
Pharmazie; 2021 Feb; 76(2):61-67. PubMed ID: 33714281
[TBL] [Abstract][Full Text] [Related]
10. Exosomes: Tunable Nano Vehicles for Macromolecular Delivery of Transferrin and Lactoferrin to Specific Intracellular Compartment.
Malhotra H; Sheokand N; Kumar S; Chauhan AS; Kumar M; Jakhar P; Boradia VM; Raje CI; Raje M
J Biomed Nanotechnol; 2016 May; 12(5):1101-14. PubMed ID: 27305829
[TBL] [Abstract][Full Text] [Related]
11. Exosomes: Nanoparticulate tools for RNA interference and drug delivery.
Shahabipour F; Barati N; Johnston TP; Derosa G; Maffioli P; Sahebkar A
J Cell Physiol; 2017 Jul; 232(7):1660-1668. PubMed ID: 28063231
[TBL] [Abstract][Full Text] [Related]
12. Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment.
Srivastava A; Rathore S; Munshi A; Ramesh R
Semin Cancer Biol; 2022 Nov; 86(Pt 1):80-100. PubMed ID: 35192929
[TBL] [Abstract][Full Text] [Related]
13. Efficient encapsulation of theranostic nanoparticles in cell-derived exosomes: leveraging the exosomal biogenesis pathway to obtain hollow gold nanoparticle-hybrids.
Sancho-Albero M; Encabo-Berzosa MDM; Beltrán-Visiedo M; Fernández-Messina L; Sebastián V; Sánchez-Madrid F; Arruebo M; Santamaría J; Martín-Duque P
Nanoscale; 2019 Oct; 11(40):18825-18836. PubMed ID: 31595912
[TBL] [Abstract][Full Text] [Related]
14. State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review.
Donoso-Quezada J; Ayala-Mar S; González-Valdez J
Crit Rev Biotechnol; 2020 Sep; 40(6):804-820. PubMed ID: 32605394
[TBL] [Abstract][Full Text] [Related]
15. SELEX-Based Screening of Exosome-Tropic RNA.
Yamashita T; Shinotsuka H; Takahashi Y; Kato K; Nishikawa M; Takakura Y
Biol Pharm Bull; 2017; 40(12):2140-2145. PubMed ID: 29199238
[TBL] [Abstract][Full Text] [Related]
16. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
[TBL] [Abstract][Full Text] [Related]
17. Exosome mimetics: a novel class of drug delivery systems.
Kooijmans SA; Vader P; van Dommelen SM; van Solinge WW; Schiffelers RM
Int J Nanomedicine; 2012; 7():1525-41. PubMed ID: 22619510
[TBL] [Abstract][Full Text] [Related]
18. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles.
Kooijmans SAA; Stremersch S; Braeckmans K; de Smedt SC; Hendrix A; Wood MJA; Schiffelers RM; Raemdonck K; Vader P
J Control Release; 2013 Nov; 172(1):229-238. PubMed ID: 23994516
[TBL] [Abstract][Full Text] [Related]
19. Exosomes as drug carriers for clinical application.
Di C; Zhang Q; Wang Y; Wang F; Chen Y; Gan L; Zhou R; Sun C; Li H; Zhang X; Yang H; Zhang H
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S564-S570. PubMed ID: 30431368
[TBL] [Abstract][Full Text] [Related]
20. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
